趋化因子在癌症免疫治疗中的新作用
Emerging Roles of Chemokines in Cancer Immunotherapy.
作者信息
Moser Bernhard
机构信息
Division of Infection & Immunity, Henry Wellcome Building, Cardiff University School of Medicine, Heath, Cardiff CF14 4XN, UK.
出版信息
Cancers (Basel). 2022 Jul 23;14(15):3593. doi: 10.3390/cancers14153593.
Abstract
This series of 15 articles (4 original articles and 11 reviews) is presented by international leaders in chemokine research [...].
摘要
这一系列15篇文章（4篇原创文章和11篇综述）由趋化因子研究领域的国际知名专家撰写[……]
相似文献
1
Emerging Roles of Chemokines in Cancer Immunotherapy.趋化因子在癌症免疫治疗中的新作用
Cancers (Basel). 2022 Jul 23;14(15):3593. doi: 10.3390/cancers14153593.
2
Chemokine-chemokine receptors in cancer immunotherapy.趋化因子-趋化因子受体在癌症免疫治疗中的作用。
Immunotherapy. 2009 Jan;1(1):109-27. doi: 10.2217/1750743X.1.1.109.
3
Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy.趋化因子及其受体：癌症免疫治疗的新靶点。
Front Immunol. 2019 Mar 6;10:379. doi: 10.3389/fimmu.2019.00379. eCollection 2019.
4
Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.趋化因子/趋化因子受体在肿瘤发生中的作用研究进展：以胰腺癌为例。
Eur J Pharmacol. 2024 Mar 15;967:176357. doi: 10.1016/j.ejphar.2024.176357. Epub 2024 Feb 1.
5
Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.趋化因子调节肿瘤发生、转移和免疫治疗反应中的免疫监视。
Front Immunol. 2019 Feb 27;10:333. doi: 10.3389/fimmu.2019.00333. eCollection 2019.
6
Antichemokine immunotherapy for allergic diseases.用于过敏性疾病的抗趋化因子免疫疗法。
Curr Opin Allergy Clin Immunol. 2001 Dec;1(6):561-7. doi: 10.1097/00130832-200112000-00012.
7
The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy.趋化因子 CXCL14 作为癌症治疗的潜在免疫治疗药物。
Viruses. 2024 Feb 16;16(2):302. doi: 10.3390/v16020302.
8
Advances in Lung Cancer Imaging and Therapy.肺癌成像与治疗的进展
Cancers (Basel). 2021 Dec 23;14(1):58. doi: 10.3390/cancers14010058.
9
The use of cytokines and chemokines in the cancer immunotherapy.细胞因子和趋化因子在癌症免疫治疗中的应用。
Recent Pat Anticancer Drug Discov. 2013 May;8(2):126-42.
10
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.癌症微环境中的趋化因子及其在癌症免疫治疗中的相关性。
Nat Rev Immunol. 2017 Sep;17(9):559-572. doi: 10.1038/nri.2017.49. Epub 2017 May 30.
引用本文的文献
1
CXCR2 expression during melanoma tumorigenesis controls transcriptional programs that facilitate tumor growth.CXCR2 在黑色素瘤发生过程中的表达控制着促进肿瘤生长的转录程序。
Mol Cancer. 2023 Jun 3;22(1):92. doi: 10.1186/s12943-023-01789-9.
本文引用的文献
1
CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy.肿瘤微环境中的CXCR4/CXCL12活性及其对肿瘤免疫治疗的意义
Cancers (Basel). 2022 May 6;14(9):2314. doi: 10.3390/cancers14092314.
2
Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes.人乳腺癌中PD-L1的肿瘤细胞自主促转移活性由PD-L1-S283和趋化因子轴介导。
Cancers (Basel). 2022 Feb 18;14(4):1042. doi: 10.3390/cancers14041042.
3
The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy.病毒驱动的致癌途径中的趋化因子系统：癌症免疫治疗的前景
Cancers (Basel). 2022 Feb 8;14(3):848. doi: 10.3390/cancers14030848.
4
Chemokines as Regulators of Neutrophils: Focus on Tumors, Therapeutic Targeting, and Immunotherapy.趋化因子作为中性粒细胞的调节因子：聚焦肿瘤、治疗靶点与免疫疗法
Cancers (Basel). 2022 Jan 28;14(3):680. doi: 10.3390/cancers14030680.
5
Chemokine Receptor-Targeted Therapies: Special Case for CCR8.趋化因子受体靶向疗法：CCR8的特殊情况
Cancers (Basel). 2022 Jan 20;14(3):511. doi: 10.3390/cancers14030511.
6
Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer.CXCL13/CXCR5信号通路在癌症免疫检查点抑制剂治疗中的潜在作用
Cancers (Basel). 2022 Jan 7;14(2):294. doi: 10.3390/cancers14020294.
7
Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma.胶质瘤中趋化因子受体表达与功能的患者导向视角
Cancers (Basel). 2021 Dec 28;14(1):130. doi: 10.3390/cancers14010130.
8
Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?癌症免疫治疗领域中的趋化因子：它们及其受体如何用于将冷肿瘤转变为热肿瘤？
Cancers (Basel). 2021 Dec 16;13(24):6317. doi: 10.3390/cancers13246317.
9
Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy.通过拮抗CXCR2抑制髓源性抑制细胞向肿瘤微环境募集以增强免疫治疗疗效
Cancers (Basel). 2021 Dec 15;13(24):6293. doi: 10.3390/cancers13246293.
10
Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity.趋化因子和趋化因子受体在肿瘤免疫中的多方面作用
Cancers (Basel). 2021 Dec 6;13(23):6132. doi: 10.3390/cancers13236132.
Zotero 插件